Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $45.0 million.

  • Bio-Techne's Accumulated Expenses fell 1598.69% to $45.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $45.0 million, marking a year-over-year decrease of 1598.69%. This contributed to the annual value of $65.8 million for FY2025, which is 3206.27% up from last year.
  • As of Q4 2025, Bio-Techne's Accumulated Expenses stood at $45.0 million, which was down 1598.69% from $43.6 million recorded in Q3 2025.
  • Bio-Techne's 5-year Accumulated Expenses high stood at $65.8 million for Q2 2025, and its period low was $28.6 million during Q4 2022.
  • Over the past 5 years, Bio-Techne's median Accumulated Expenses value was $43.8 million (recorded in 2021), while the average stood at $44.9 million.
  • In the last 5 years, Bio-Techne's Accumulated Expenses surged by 8470.08% in 2021 and then tumbled by 4068.57% in 2023.
  • Over the past 5 years, Bio-Techne's Accumulated Expenses (Quarter) stood at $43.9 million in 2021, then tumbled by 34.81% to $28.6 million in 2022, then increased by 15.23% to $33.0 million in 2023, then skyrocketed by 62.43% to $53.6 million in 2024, then fell by 15.99% to $45.0 million in 2025.
  • Its last three reported values are $45.0 million in Q4 2025, $43.6 million for Q3 2025, and $65.8 million during Q2 2025.